It is easy to tell that this year‘s cold season, which started at the end of summer with a relatively high number of infections, is now fully on: runny noses, cough, etc. are bringing more and more patients: Runny noses, cough, etc. are bringing more and more patients into the doctor’s practices, as did the Pertussis wave in the middle of the year. And Mycoplasma pneumoniae also worries the experts: The infection rate is much higher than in previous years. These infection events may also drive the number of people on sick leave further up in the coming months (the number in Germany has already broken a record in 2024). In order to help reverse this trend using diagnostics, EUROIMMUN offers a comprehensive test range for respiratory pathogens based on real-time PCR (manufactured by ALPCO Geneproof) in addition to the EUROArray PneuVir and EURORealTime RSV A/B.
Whether you want to use real-time PCR to detect respiratory pathogens or would like to expand your pathogen detection using the EUROArray PneuVir by bacterial pathogens, the GeneProof assays are the right choice. They cover the following parameters:
- Adenovirus
- Aspergillus
- Bordetella pertussis/parapertussis
- Chlamydia pneumoniae
- Enterovirus
- Influenza virus A
- Legionella pneumophila
- Mycobacterium tuberculosis
- Mycoplasma pneumoniae
- SARS-CoV-2
GeneProof’s high quality PCR kits provide fast, precise detection of the nucleic acid of infectious agents. They can be performed manually or automatically and are validated for a large number of real-time PCR cyclers. The innovative one-workflow technology not only allows for DNA and RNA to be automatically extracted from various materials, but also provides a uniform PCR workflow with identical reaction conditions. Consequently, in one PCR plate, several assays can be combined as required in one run, increasing efficiency and convenience in your daily lab routine, not least due to the ready-for-use mastermix and reagents provided.
This cold season, be prepared with the GeneProof portfolio for diagnostics of respiratory tract infections, our molecular diagnostic portfolio and the comprehensive range for supplementary serological diagnostics!
